May 08, 2025 / 09:00PM GMT
Operator
Good afternoon and welcome to the Abcellera's first quarter 2025 business update and conference call.
My name is Jasmine and I will facilitate the audio portion of today's interactive broadcast.
(Operator Instructions)
At this time I would like to turn the call over to Tryn Stimart as Chief Legal and Compliance Officer. You may proceed.
Tryn Stimart - Abcellera Biologics Inc - Chief Compliance Officer, Corporate Secretary, Chief Legal Officer
Thank you. Hello everyone.
Thank you for joining us for Abcellera's first quarter 2025 earnings call. I'm Tryn Stimart of Abcellera's chief legal and compliance officer. Dr. Carl Hansen of Abcellera's President and Chief Executive Officer, and Andrew Booth, of Abcellera's Chief Financial Officer, are joining me on today's call.
During this call, we anticipate making projections and forward-looking statements based on our current expectations and according to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995.
Our actual results could
Q1 2025 Abcellera Biologics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
